A study to understand the tolerability, utilitization pattern and effects of Minocycline oral formulatio
Not Applicable
- Conditions
- Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue
- Registration Number
- CTRI/2023/08/056338
- Lead Sponsor
- Sun Pharma Industries Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients >=12 years of age
Patients prescribed with oral minocycline formulations
Patients with a minimum of 1 follow-up visit data from the index date (first prescription) of oral minocycline formulations
Exclusion Criteria
Patients not on oral minocycline treatment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method